These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 17637191)
1. Inhibition of P-glycoprotein function by tannic acid and pentagalloylglucose. Kitagawa S; Nabekura T; Nakamura Y; Takahashi T; Kashiwada Y J Pharm Pharmacol; 2007 Jul; 59(7):965-9. PubMed ID: 17637191 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of P-glycoprotein function by tea catechins in KB-C2 cells. Kitagawa S; Nabekura T; Kamiyama S J Pharm Pharmacol; 2004 Aug; 56(8):1001-5. PubMed ID: 15285844 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of P-glycoprotein function by procyanidine on blood-brain barrier. He L; Zhao C; Yan M; Zhang LY; Xia YZ Phytother Res; 2009 Jul; 23(7):933-7. PubMed ID: 19172664 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of P-glycoprotein and multidrug resistance protein 1 by dietary phytochemicals. Nabekura T; Yamaki T; Ueno K; Kitagawa S Cancer Chemother Pharmacol; 2008 Oct; 62(5):867-73. PubMed ID: 18204840 [TBL] [Abstract][Full Text] [Related]
6. Effect of triterpenoids isolated from the floral spikes of Betula platyphylla var. japonica on P-glycoprotein function. Sekiya M; Kashiwada Y; Nabekura T; Kitagawa S; Yamagishi T; Yokozawa T; Ichiyanagi T; Ikeshiro Y; Takaishi Y Planta Med; 2007 Dec; 73(15):1558-62. PubMed ID: 18058609 [TBL] [Abstract][Full Text] [Related]
7. Characterization of P-glycoprotein inhibition by major cannabinoids from marijuana. Zhu HJ; Wang JS; Markowitz JS; Donovan JL; Gibson BB; Gefroh HA; Devane CL J Pharmacol Exp Ther; 2006 May; 317(2):850-7. PubMed ID: 16439618 [TBL] [Abstract][Full Text] [Related]
8. Modulation of multidrug resistant in cancer cells by EGCG, tannic acid and curcumin. Li H; Krstin S; Wink M Phytomedicine; 2018 Nov; 50():213-222. PubMed ID: 30466981 [TBL] [Abstract][Full Text] [Related]
9. Effects of chemopreventive citrus phytochemicals on human P-glycoprotein and multidrug resistance protein 1. Nabekura T; Yamaki T; Kitagawa S Eur J Pharmacol; 2008 Dec; 600(1-3):45-9. PubMed ID: 18955043 [TBL] [Abstract][Full Text] [Related]
10. Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells. Li X; Sun B; Zhu CJ; Yuan HQ; Shi YQ; Gao J; Li SJ; Lou HX Toxicol In Vitro; 2009 Feb; 23(1):29-36. PubMed ID: 18938236 [TBL] [Abstract][Full Text] [Related]
11. Cholesterol interaction with the daunorubicin binding site of P-glycoprotein. Wang E; Casciano CN; Clement RP; Johnson WW Biochem Biophys Res Commun; 2000 Oct; 276(3):909-16. PubMed ID: 11027568 [TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of ginsenosides and their hydrolyzed metabolites on daunorubicin transport in KB-C2 cells. Kitagawa S; Takahashi T; Nabekura T; Tachikawa E; Hasegawa H Biol Pharm Bull; 2007 Oct; 30(10):1979-81. PubMed ID: 17917277 [TBL] [Abstract][Full Text] [Related]
13. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells. Wang TX; Yang XH Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331 [TBL] [Abstract][Full Text] [Related]
14. CJY, an isoflavone, reverses P-glycoprotein-mediated multidrug-resistance in doxorubicin-resistant human myelogenous leukaemia (K562/DOX) cells. Ji BS; He L J Pharm Pharmacol; 2007 Jul; 59(7):1011-5. PubMed ID: 17637197 [TBL] [Abstract][Full Text] [Related]
15. Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid induces down-regulation of P-glycoprotein expression and transport activity. Sulová Z; Macejová D; Seres M; Sedlák J; Brtko J; Breier A Toxicol In Vitro; 2008 Feb; 22(1):96-105. PubMed ID: 17920233 [TBL] [Abstract][Full Text] [Related]
16. Reversal effect of substituted 1,3-dimethyl-1H-quinoxalin-2-ones on multidrug resistance in adriamycin-resistant K562/A02 cells. Sun LR; Li X; Cheng YN; Yuan HY; Chen MH; Tang W; Ward SG; Qu XJ Biomed Pharmacother; 2009 Mar; 63(3):202-8. PubMed ID: 18818047 [TBL] [Abstract][Full Text] [Related]
17. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells. Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169 [TBL] [Abstract][Full Text] [Related]
18. Differences in assessment of macrolide interaction with human MDR1 (ABCB1, P-gp) using rhodamine-123 efflux, ATPase activity and cellular accumulation assays. Munić V; Kelnerić Z; Mikac L; Eraković Haber V Eur J Pharm Sci; 2010 Sep; 41(1):86-95. PubMed ID: 20621639 [TBL] [Abstract][Full Text] [Related]
19. [Effect of prolonged ingestion of tannic acid, potassium metabisulfite and ethanol, administered alone or in combination, on the liver vitamin A concentration in the rat]. Suschetet M Int J Vitam Nutr Res; 1975; 45(2):129-37. PubMed ID: 1165160 [TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationship and mechanism of flavonoids on the inhibitory activity of P-glycoprotein (P-gp)-mediated transport of rhodamine123 and daunorubicin in P-gp overexpressed human mouth epidermal carcinoma (KB/MDR) cells. Fang Y; Liang F; Xia M; Cao W; Pan S; Wu T; Xu X Food Chem Toxicol; 2021 Sep; 155():112381. PubMed ID: 34217736 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]